Equity
€122,302 from €2.3m in 2017
Equity fell by 95% in 8 years.
APOTHEEK MEES ZONHOVEN
Lifetime
20 annual accounts with figures on one time axis, 41 filings since 1985peak €286,326 (2009)
€215,185▲ 2.4%
lowest -€7,197 (2018)
€111,802▼ 1.8%
peak €2.3m (2017)
€122,302unchanged
€325,512▼ 3.3%
peak 3.7 FTE (2016)
1 FTEunchanged
Board3 names since 2012
2 directorsMees Management Apotheek BV and 1 other
Owners2 names in the annual accounts
Documentsfilings and deeds
08-06-202653 days before the deadline
2025abbreviated format
Dividend €47,802Cash from €79,874 to €109,855
Key points
from the 2025 annual accountsChecked score
92
Excellent
Financially stronger than 53% of micro companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,276 companies (NACE 47, micro).
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026highest value
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.1%▼ -0.1 percentage points vs 06-2026lowest value
08-2026: 0.1%● unchanged vs 07-2026lowest value
09-2026: 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026lowest value
11-2026: 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Sector: Retail trade (NACE 47)
lowers risk
Founded in 1985
Liquidity: current ratio 1.38, cash €109,855
Legal form: public limited company
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 43% of them on solvency, 40% on liquidity, 91% on profitability and 39% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,818 companies had the same profile as APOTHEEK MEES ZONHOVEN has now. Each dot stands for 10 companies, two years later.
95.1%
were still trading
3.7%
stopped another way
1.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of APOTHEEK MEES ZONHOVEN itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,818 companies, not a prediction for APOTHEEK MEES ZONHOVEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.38 (1.35 in 2024), below the usual 1.5. Short-term debt is 72.1% and cash 24.5% of total assets. 72.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
53 days early
2024
56 days early
2023
48 days early
2022
52 days early
2021
34 days early
2020
61 days early
2019
44 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 50 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
IB
INVISIO BV
Director, HAYEN Véronique, since 01-09-2020
- MEES MANAGEMENT APOTHEEK 100%equity €20.1m (2025) · 2025 annual accounts of MEES MANAGEMENT APOTHEEK
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0428121970
Company renamed from APOTHEEK BAETEN to APOTHEEK MEES ZONHOVEN
“De exploitatie,huur en verhuur van één of meer apotheken; Het verzorgen van vervangingen van en voor één of…” (deed in Dutch) · General meeting of 17-05-2021 · Gazette deed
1 director appointed, 1 resignation, 1 reappointment
Resignation: WOUTERS Maria · Appointment: INVISIO BV · Permanent representatives: HAYEN Véronique and Mees Joris · General meeting of 01-09-2020 · Gazette deed
Incorporation
published on 11-12-1985 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| APOTHEEK MEES ZONHOVEN Zonhoven | €447,814 | €215,185 | 27.3% | 1 |
| APOTHEEK COLLIN Gingelom | €448,340 | €218,774 | 23.5% | 0.8 |
| Apotheek Ernens Sint-Truiden | €509,057 | €217,175 | 31.4% | 1.2 |
| APOTHEEK VLIJTINGEN Riemst | €540,253 | €168,467 | 22.8% | 0.9 |
| Apotheek Sofie Verhaeghe Roeselare | €524,962 | €214,808 | 53.2% | 1 |
| APOTHEEK MOLENVELD Grimbergen | €456,885 | €246,411 | 31.2% | 0.8 |
| MEDIFAR Izegem | €490,803 | €176,068 | 71.7% | 1 |
These companies have the same main activity as APOTHEEK MEES ZONHOVEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €448,000 and €540,000, founded between 1983 and 1987.
Official details
Source: KBO- Status
- Active since 17-11-1985Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 1 other
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.028.394.7143520 Zonhoven, since 01-07-1985
- Financial year end
- 31 December
- Peppol
- Reachable since 01-10-2025
Annual accounts 2025
- ≈ €1.0mestimated
- €447,814▼ 2.4%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 08-06-2026, 53 days before the end of the filing period
Insights on APOTHEEK MEES ZONHOVEN
APOTHEEK MEES ZONHOVEN files the abbreviated format. That format states no turnover. The gross margin rose from €185,277 in 2006 to €215,185 in 2025.
MEES MANAGEMENT APOTHEEK holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APOTHEEK MEES ZONHOVEN
- What is the company number of APOTHEEK MEES ZONHOVEN?
- The company number of APOTHEEK MEES ZONHOVEN is 0428.121.970. The VAT number is the same number with BE in front: BE 0428.121.970.
- Where is APOTHEEK MEES ZONHOVEN based?
- The registered office is at Dorpsstraat 6-8, 3520 Zonhoven.Company details
- What does APOTHEEK MEES ZONHOVEN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK MEES ZONHOVEN?
- APOTHEEK MEES ZONHOVEN is a public limited company (NV).
- When was APOTHEEK MEES ZONHOVEN founded?
- APOTHEEK MEES ZONHOVEN was founded on 17-11-1985.
- Is APOTHEEK MEES ZONHOVEN still active?
- Yes, APOTHEEK MEES ZONHOVEN is an active enterprise in the KBO register.
- How many employees does APOTHEEK MEES ZONHOVEN have?
- APOTHEEK MEES ZONHOVEN had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK MEES ZONHOVEN fall under?
- In its 2025 annual accounts, APOTHEEK MEES ZONHOVEN states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of APOTHEEK MEES ZONHOVEN?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €215,185 and 51 comparable companies (NACE 477). It probably lies between €670,000 and €1.9m.
- Is APOTHEEK MEES ZONHOVEN profitable?
- In financial year 2025, APOTHEEK MEES ZONHOVEN made a profit of €111,802.
- Where can I find the annual accounts of APOTHEEK MEES ZONHOVEN?
- APOTHEEK MEES ZONHOVEN filed 41 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK MEES ZONHOVEN due?
- APOTHEEK MEES ZONHOVEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies See the other companies in the same group.MEES MANAGEMENT APOTHEEK · 24 companies
See how customers, suppliers and banks see your own company and what to improve first.